Study of Compliance of Diabetic Patients to Prescribed Medication

Hameed, Amber; Rashid, Tehreem; Amin, Washma

doi:10.29322/ijsrp.9.06.2019.p90132

Cited by 2 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One of the important factors that influence compliance in chronic disease management is a good doctor-patient relationship [11]. Clinicians should take responsibility for providing education about the disease like the progression of DM and awareness about its complication, the importance of glycemic control, lifestyle modification, the essential need for regular intake of medicine, and side effects of medication [23]. Training of individuals provides knowledge and skills to become active in self-care [19].…”

Section: Discussionmentioning

confidence: 99%

Compliance of Appointment, Antidiabetic Treatment, and Diet in Type 2 Diabetes Mellitus Patients at Private Diabetes Clinic

Piparva¹,

Singh²,

Joshi³

2022

Dubai Diabetes Endocrinol J

View full text Add to dashboard Cite

Context: India is an epicenter of type 2 diabetes mellitus (T2DM) in the entire world. Compliance is essential for chronic diseases treatment and has a significant impact on health and health care costs. The current study was planned to assess compliance to the appointment, treatment, and diet in T2DM patients at a private diabetic clinic in Rajkot city. Aims: The aim was to assess compliance to physician’s appointment, antidiabetic treatment, and diet among T2DM patients attending private diabetic clinic at Rajkot city. Settings and Design: This was an interview-based, prospective study done at a private diabetes clinic. Methods and Material: T2DM patients (>18 years) of either gender who were on antidiabetic treatment (at least 3 months before enrollment) at a private outpatient diabetic clinic during 2019 were included after ethical approval and obtaining informed consent. Juvenile diabetes, gestational diabetes, and noncompliant T2DM patients were excluded. Statistical Analysis Used: The χ2 test was used for the statistical association of sociodemographic and disease variables with compliance using GraphPad version 7 (p value <0.05 was considered significant). Results: Of 370 enrolled patients, 21 patients were lost to follow-up (noncompliant). From 349 T2DM patients, the majority of patients were in the middle age-group (60%, 41–60 years), preobese and obese (69.99%), and with comorbidity (42.7%). Compliance to appointment, treatment, and diet was observed above 85% in this study. Old age (>60 years) was significantly associated with poor appointment compliance, and comorbidity is significantly associated with the poor appointment, treatment, and diet compliance. An increasing number of comorbidities were significantly associated with poor appointment compliance. Conclusions: A higher compliance to appointment, treatment, and diet was achieved.

show abstract

Section: Discussionmentioning

confidence: 99%

Compliance of Appointment, Antidiabetic Treatment, and Diet in Type 2 Diabetes Mellitus Patients at Private Diabetes Clinic

Piparva¹,

Singh²,

Joshi³

2022

Dubai Diabetes Endocrinol J

View full text Add to dashboard Cite

show abstract

“…In Pakistan estimated prevalence of diabetes mellitus is about 17.1% 1 with compliance of only 60 % with prescribed anti diabetic medications. 2 Diabetes mellitus Type-2 (T2DM) is a slowly progressive metabolic disorder characterized by insulin resistance and a progressive defect in insulin secretion associated with severe macrovascular and microvascular complications. 3 Because of its progressive nature, it needs multiple anti-diabetic agents for achieving and maintaining optimum glycemic control, unfortunately, more than 50 to 70% of patients with T2DM failed to achieve and maintain their glycemic control at some stage.…”

Section: Introductionmentioning

confidence: 99%

Clinical outcomes of Sodium-glucose cotransporter-2 inhibitors in patients with Type 2 Diabetes Mellitus: An observational study from Pakistan

Das¹,

Sheikh²,

Ahmed³

et al. 2021

Pak J Med Sci

View full text Add to dashboard Cite

Objective: To determine the efficacy and safety of Sodium-glucose cotransporter-2 inhibitors (SGLT2i) use in the Pakistani population. Methods: Retrospective review of initial 100 patients who were prescribed with any agent of the SGLT2i group from July 1, 2018 to January 2019 at Aga Khan University Hospital, Karachi. SGLT2i was offered to patients of above 18 years of age with inadequate glycemic control on existing antidiabetic agents. Changes in HbA1c, the Body Mass Index (BMI), serum creatinine, any decrease in the requirement of insulin and sulphonylurea dose along with any side effects reported by the patients on follow-up visits. Results: Most study participants were females (56%) with the mean age of 52±10 years. Substantial changes were observed in the HbA1c (7.5±1.1%, 7.9±1.2% from 8.7±1.5%, p < 0.01), BMI (31.4±5.8, 31.8±5.8 from 32.4±5.9kg/m2, p < 0.01) and in creatinine (0.71±0.1, 0.75±0.1 from 0.79±0.1 mg/dl, p < 0.01) at three and six months of follow up visits. The reduction in insulin and sulphonylurea doses was also significant. Adverse drug events that led to drug discontinuation in 14 individuals were, Urinary tract infection (UTI) (seven patients), Genital infection (three patients), nausea +UTI, abdominal pain +UTI, mild Diabetic Ketoacidosis, and polyuria (one patient each). None reported Fournier’s gangrene, limb amputation, or fracture. Conclusion: SGLT2i significantly improved glycemic control, BMI, and serum creatinine in the Pakistani population with a very low number of observed adverse events. doi: https://doi.org/10.12669/pjms.37.5.3901 How to cite this:Das B, Sheikh A, Ahmed B, Islam N. Clinical outcomes of Sodium-glucose cotransporter-2 inhibitors in patients with Type 2 Diabetes Mellitus: An observational study from Pakistan. Pak J Med Sci. 2021;37(5):---------. doi: https://doi.org/10.12669/pjms.37.5.3901 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

show abstract

Study of Compliance of Diabetic Patients to Prescribed Medication

Cited by 2 publications

References 9 publications

Compliance of Appointment, Antidiabetic Treatment, and Diet in Type 2 Diabetes Mellitus Patients at Private Diabetes Clinic

Compliance of Appointment, Antidiabetic Treatment, and Diet in Type 2 Diabetes Mellitus Patients at Private Diabetes Clinic

Clinical outcomes of Sodium-glucose cotransporter-2 inhibitors in patients with Type 2 Diabetes Mellitus: An observational study from Pakistan

Contact Info

Product

Resources

About